Skip to main content

Molybdenum-99 for Medical Imaging (2016) / Chapter Skim
Currently Skimming:

References
Pages 201-212

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 201...
... Presentation to the Committee on State of Molybdenum-99 Production and Utilization and Progress toward Eliminating Use of Highly Enriched Uranium, Ottawa, Canada, December 16. Ottawa: Natural Resources Canada; Ottawa: Health Canada.
Read the entire page →
From page 202...
... 2009. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid As sociation (ATA)
Read the entire page →
From page 203...
... Presentation to the Committee on State of Molybdenum-99 Production and Utilization and Progress toward Eliminating Use of Highly Enriched Uranium, Ottawa, Canada, December 16. Saskatoon: Canadian Isotope Innovations Corp.
Read the entire page →
From page 204...
... 2011. GE Hitachi Nuclear Energy and Exelon announce the potential production of critical medical isotope at Clinton Power Station, GEH also signs memoranda of understanding with NuView Life Sciences and NorthStar Medical Radio isotopes for potential processing facilities.
Read the entire page →
From page 205...
... Vienna, Austria: International Atomic Energy Agency. Available at http://www-pub.iaea.org/MTCD/Publications/PDF/ Pub1589_web.pdf (accessed August 31, 2016)
Read the entire page →
From page 206...
... 2014. 2012-13 Blue Room Low Enriched Uranium Sample Irradiation, As sociated Gas Handling System, and Subsequent Separation Chemistry.
Read the entire page →
From page 207...
... 2009. Radiologic and Nuclear Medicine Studies in the United States and Worldwide: Frequency, Radiation Dose, and Comparison with Other Radiation Sources -- 1950–2007.
Read the entire page →
From page 208...
... 2014a. NorthStar Medical Radioisotopes signs letter of intent with GE Healthcare: Relationship will help create a reliable domestic source of vital radioisotope produced without the use of highly enriched uranium.
Read the entire page →
From page 209...
... 2014. Perma-Fix Medical Announces Validation of Medical Isotope Technology with Leading International Reactor Operators: New Pro cess to Produce Technetium-99m Eliminates the Need for Both High and Low Enriched Uranium Targets.
Read the entire page →
From page 210...
... Presentation to the Committee on State of Molybdenum-99 Production and Utilization and Progress toward Eliminating Use of Highly Enriched Uranium, Ottawa, Canada, December 16. Winnipeg: Prairie Isotope Production Enterprise.
Read the entire page →
From page 211...
... Presentation to the Com mittee on State of Molybdenum-99 Production and Utilization and Progress toward Eliminating Use of Highly Enriched Uranium at Argonne National Laboratories, Lemont, IL, May 12. Lemont, IL: Argonne National Laboratory.
Read the entire page →
From page 212...
... ANL/CSE-14/24. Chicago, Illinois: Argonne National Laboratory.
Read the entire page →

Key Terms

  • enriched uranium
  • medical isotope
  • highly enriched
  • nuclear medicine
  • medical imaging

  • press release
  • nuclear energy
  • accessed september
  • energy agency
  • isotope production

  • research reactor
  • medical radioisotopes
  • northstar medical
  • isotope supply
  • international atomic

  • thyroid nodules
  • oecd nuclear
  • american thyroid
  • rertr meeting
  • differentiated thyroid

  • thyroid cancer
  • international rertr
  • argonne national
  • national nuclear
  • nuclear security

  • hitachi nuclear
  • million medical
  • management guidelines
  • security administration
  • medicine professional


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.